In previous studies, immunohistochemical analysis revealed the expression of wild-type MST1R in various cancerous and adjacent cancerous tissues, including pancreatic and prostate cancers (Batth et al. 2021; Li et al. 2019). This evidence concerns the gene MST1R and prostate carcinoma.